ECNP Supported Talks 2016
11 October 2016
ECNP Supported Talk: Developmental trajectories in early-onset psychoses: open windows for prevention? by Celso Arango, Spain, at the XIX National Congress of the Society, Sicily, Italy.
9 October 2016
ECNP Supported Talk: Therapeutic intervention for early onset psychoses: current limitations and opportunities by Carmen Moreno, Spain at the XXVII National Congress of the Italian Society of Child & Adolescent Neuropsychiatry Alghero, Sardinia, Italy.
9 September 2016
ECNP Supported Talk: Suicide prevention strategies revisited: 10 year systematic review by Gil Zalsman, Israel at the 16th European Symposium on Suicide and Suicidal behaviour, Oviedo, Spain
30 July 2016
ECNP Supported Talk: Neuroscience Based Nomenclature (NbN) – Can neuroscience change an outdated psychotropic classification?
By Joseph Zohar at the AFCNP 2nd annual conference of the African College of Neuropsychopharmacology, Cape Town, South Africa
5 July 2016
ECNP Supported Talk: Suicide in young people
By Alan Apter at the 'Mind the Gap' 24th EFPT Forum, Antwerp, Belgium
17 June 2016
ECNP Supported Talk: The Neuroscience-based Nomenclature (NbN): What it means for you as a clinician by Joseph Zohar at the Yerevan State Medical University, Yerevan, Armenia
29 April 2016
ECNP Supported Talk: Evidence based treatment for Schizophrenia by Michael Davidson at the WPA 2016 Regional Conference "Mental Health, Direction and Challenges, Tbilisi, Georgia
06 May 2016
ECNP Supported Talk: How Neuroscience based Nomenclature (NbN) can help in rational prescribing? by Joseph Zohar at the International conference 'Anxiety and Stressor-Related Disorders: from diagnostic challenge to evidence-based treatment', Kaunas, Lithuania
Report
19 February 2016
ECNP Supported Talk: How Neuroscience based Nomenclature (NbN) can help in rational prescribing by Joseph Zohar at the Stand alone meeting
Psychiatric Clinic “Dr Laza Lazarevic, Belgrade, Serbia
Pictures
Report
29 January 2016
ECNP mini-symposium: "Altering the disease course in neuropsychiatric disorders", Stockholm, Sweden
Report
